BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bhanat E, Koch CA, Parmar R, Garla V, Vijayakumar V. Somatostatin receptor expression in non-classical locations – clinical relevance? Rev Endocr Metab Disord 2018;19:123-32. [DOI: 10.1007/s11154-018-9470-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Gubbi S, Koch CA, Klubo-Gwiezdzinska J. Peptide Receptor Radionuclide Therapy in Thyroid Cancer. Front Endocrinol (Lausanne) 2022;13:896287. [PMID: 35712243 DOI: 10.3389/fendo.2022.896287] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Helgebostad R, Revheim M, Johnsrud K, Amlie K, Alavi A, Connelly JP. Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine Tumors. Diagnostics 2022;12:528. [DOI: 10.3390/diagnostics12020528] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ragab A, Wu J, Ding X, Clark A, Mischen B, Chauhan A, Oates ME, Anthony L, El Khouli R. 68Ga-DOTATATE PET/CT: The Optimum Standardized Uptake Value (SUV) Internal Reference. Acad Radiol 2022;29:95-106. [PMID: 34756348 DOI: 10.1016/j.acra.2020.08.028] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Anzola LK, Rivera JN, Ramirez JC, Signore A, Mut F. Molecular Imaging of Vulnerable Coronary Plaque with Radiolabeled Somatostatin Receptors (SSTR). J Clin Med 2021;10:5515. [PMID: 34884218 DOI: 10.3390/jcm10235515] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kasprzak A. Somatostatin and Its Receptor System in Colorectal Cancer. Biomedicines 2021;9:1743. [PMID: 34829972 DOI: 10.3390/biomedicines9111743] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Liu J, Xu N, Wang X, Wang Y, Wu Q, Li X, Pan D, Wang L, Xu Y, Yan J, Li X, Yu L, Yang M. Quantitative radio-thin-layer chromatography and positron emission tomography studies for measuring streptavidin transduced chimeric antigen receptor T cells. J Chromatogr B Analyt Technol Biomed Life Sci 2021;1182:122944. [PMID: 34592686 DOI: 10.1016/j.jchromb.2021.122944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Shamsi BH, Chatoo M, Xu XK, Xu X, Chen XQ. Versatile Functions of Somatostatin and Somatostatin Receptors in the Gastrointestinal System. Front Endocrinol (Lausanne) 2021;12:652363. [PMID: 33796080 DOI: 10.3389/fendo.2021.652363] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
8 Johnbeck CB, Mortensen J. Somatostatin Receptor Imaging PET in Neuroendocrine Neoplasm. PET Clin 2021;16:191-203. [PMID: 33648664 DOI: 10.1016/j.cpet.2020.12.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Özgüven S, Filizoğlu N, Kesim S, Öksüzoğlu K, Şen F, Öneş T, İnanır S, Turoğlu HT, Erdil TY. Physiological Biodistribution of 68Ga-DOTA-TATE in Normal Subjects. Mol Imaging Radionucl Ther 2021;30:39-46. [PMID: 33586406 DOI: 10.4274/mirt.galenos.2021.37268] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
10 Hu Y, Huang J. The Chimeric Antigen Receptor Detection Toolkit. Front Immunol 2020;11:1770. [PMID: 32849635 DOI: 10.3389/fimmu.2020.01770] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
11 Anzola LK, Glaudemans AWJM, Dierckx RAJO, Martinez FA, Moreno S, Signore A. Somatostatin receptor imaging by SPECT and PET in patients with chronic inflammatory disorders: a systematic review. Eur J Nucl Med Mol Imaging 2019;46:2496-513. [PMID: 31463594 DOI: 10.1007/s00259-019-04489-z] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 5.8] [Reference Citation Analysis]
12 Minn I, Huss DJ, Ahn HH, Chinn TM, Park A, Jones J, Brummet M, Rowe SP, Sysa-Shah P, Du Y, Levitsky HI, Pomper MG. Imaging CAR T cell therapy with PSMA-targeted positron emission tomography. Sci Adv 2019;5:eaaw5096. [PMID: 31281894 DOI: 10.1126/sciadv.aaw5096] [Cited by in Crossref: 62] [Cited by in F6Publishing: 64] [Article Influence: 15.5] [Reference Citation Analysis]
13 Koch CA, Antonelli A. Immunoendocrinology: When (neuro)endocrinology and immunology meet. Rev Endocr Metab Disord 2018;19:277-82. [PMID: 30656554 DOI: 10.1007/s11154-018-9479-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
14 Koch CA, Krabbe S, Hehmke B. Statins, metformin, proprotein-convertase-subtilisin-kexin type-9 (PCSK9) inhibitors and sex hormones: Immunomodulatory properties? Rev Endocr Metab Disord 2018;19:363-95. [DOI: 10.1007/s11154-018-9478-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
15 Koch CA, Petersenn S. Neuroendocrine neoplasms – think about it and choose the most appropriate diagnostic and therapeutic steps. Rev Endocr Metab Disord 2018;19:107-9. [DOI: 10.1007/s11154-018-9472-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]